MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Within patient comparison of neurostimulator longevity; sequentially contrasting the Medtronic Activa PC to the Medtronic Percept PC utilizing in-device battery estimates

    E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)

    Objective: To examine the differences between Actual Activa PC longevity and the estimated longevity of the Percept PC, utilizing identical contact configurations and programming parameters.…
  • 2022 International Congress

    Social cognition in patients with cerebellar neurodegenerative disorders

    O. Tamas, M. Kostic, A. Kacar, A. Milovanovic, B. Salak Djokic, D. Stanisavljevic, E. Stefanova, N. Dragasevic Miskovic (Belgrade, Serbia)

    Objective: The aim of this study was to investigate social cognition (SC) in patients with different cerebellar neurodegenerative disorders (CDs). Background: CDs are a heterogeneous…
  • 2022 International Congress

    Outcomes after Deep Brain Stimulation (DBS) surgery in patients with young-onset Parkinson’s disease

    L. Jackson, B. Klassen, K. Lee, K. Miller, A. Hassan, R. Savica (Rochester, USA)

    Objective: To assess outcomes after deep brain stimulation (DBS) in patient with young-onset Parkinson’s disease (PD). Background: DBS is a surgical procedure which effectively treats…
  • 2022 International Congress

    Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

    L. Batzu, S. Rota, A. Hye, A. Heslegrave, D. Trivedi, L. Gibson, C. Farrell, P. Zinzalias, A. Rizos, H. Zetterberg, K. Ray Chaudhuri, D. Aarsland (London, United Kingdom)

    Objective: To investigate the association of plasma p-tau181 and NfL with cognitive performance and cognitive progression in PD patients. Background: Cognitive impairment (CI) is a…
  • 2022 International Congress

    Safety and Efficacy of Verdiperstat, a Novel Myeloperoxidase Inhibitor, in MSA

    I. Qureshi, V. Wirtz, L. Brady, J. Ellison, A. Ellenbogen, R. Freeman, G. Höglinger, H. Kaufmann, A. Lang, P. Low, W. Meissner, P. Millar Vernetti, H. Morris, J. Palma, S. Perlman, W. Poewe, J. Schmahmann, K. Seppi, W. Singer, S. Vernino, G. Wenning (New Haven, USA)

    Objective: To present results from M-STAR, a phase 3, randomized controlled trial evaluating the disease modifying effect of verdiperstat in participants with MSA. Background: MSA…
  • 2022 International Congress

    Brain glia activation and peripheral inflammation in Parkinson’s disease: a PET study

    SY. Liu, HW. Qiao, TB. Song, O. Barret, FW. Qiao, XL. Liu, X. Xu, YN. Cai, G. Tamagnan, V. Sossi, P. Chan (Beijing, China)

    Objective: Abnormal activation of immune system is an important pathogenesis of Parkinson's disease, but the relationship between peripheral inflammation, central glia activation and dopaminergic degeneration…
  • 2022 International Congress

    The reliability and validity of the Ziegler test for measuring freezing of gait in people with Parkinson’s disease.

    L. Goh, S. Paul, C. Canning, K. Ehgoetz Martens, J. Song, S. Campoy, N. Allen (Camperdown, Australia)

    Objective: To determine the inter-rater and test-retest reliability of the Ziegler test to measure freezing of gait (FOG) severity in people with Parkinson’s disease (PwPD).…
  • 2022 International Congress

    Case Report: Deep Brain Stimulation as a Potential Treatment for Stiff-Person Syndrome

    E. Shah, S. Isfahani, D. Swope (Orange, USA)

    Objective: To our knowledge, there have not been any reports of deep brain stimulation (DBS) used in the treatment of stiff-person syndrome (SPS) in the…
  • 2022 International Congress

    Depression and progression of motor symptoms in early stage of Parkinson’s disease

    YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association of depression with the progression of motor symptoms in patients with early-stage PD. Background: Depression is a major nonmotor symptom…
  • 2022 International Congress

    PD+: A comprehensive, user-friendly mobile application for clinicians treating Parkinson’s Disease

    E. Shah, T. Khachatryan, N. Phielipp, S. Isfahani (Orange, USA)

    Objective: We developed a mobile application that converts dopaminergic medication dosages and calculates total Levodopa (L-dopa) equivalent daily dose (LEDD) in a Parkinson’s Disease (PD)…
  • « Previous Page
  • 1
  • …
  • 605
  • 606
  • 607
  • 608
  • 609
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley